Global

Global R&D Product Pipeline

Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise thereby ensuring our continued growth.

Our balanced research and development portfolio is divided into three categories: life cycle management, market development and new product development.

  • Lifecycle management ensures continuous product improvement by maintaining and increasing competitiveness within our existing product range.
  • Market development brings therapies to new markets and new indications by maximizing market opportunities for our existing product range.
  • New product development creates specialty therapies to treat life-threatening diseases. It ensures long-term growth primarily through projects aligned with our current marketing channels.

For a brief description of any of the products listed in our pipeline please visit the Product Pipeline Description page.

 Research /
Pre-Clinical
Clinical
Development
Registration/
Post-Launch
Life Cycle
Management
  
Immunoglobulins
Haemophilia
Specialty Products
Influenza Vaccine
Market
Development
Fibrinogen
New Indications
PCC
New Indications
Hizentra® CIDP
Fibrinogen
Aortic EU
Zemaira® EU
 Berinert® SC
Privigen® CIDP
Hizentra® biweekly
Hizentra® Japan
Voncento® EU
Zemaira® EU
Kcentra® US
Bleeding
New
Product Development
Novel
Plasma Proteins
Rec Coagulation
Factors
rvWF-FP
Partnered Vaccine Programs*
P. gingivalis/POD
CRC-OHS/Sanofi*
Discovery Projects
CSL324 G-CSFR
CSL346 VEGFB
CSL334 IL-13R
FXIIa Antagonist
CSL654 rIX-FP
CSL689 rVIIa-FP
CSL627 rVIII-SC
Partnered Vaccine programs*
CSL362 IL-3R*
Janssen
CAM3001
GM-CSFR-AZ*
CSL112
reconstituted HDL
 

Core Capabilities
Replacement Therapies Haemophilia Specialty Products Breakthrough Medicines Vaccines & IP

* Partnered Projects

For a brief description of any of the products listed in our pipeline please visit the Product Pipeline Description page.

Share
LinkedIn Twitter Facebook Google+